Dese de alta para crear alertas sobre sus instrumentos,
eventos económicos y autores favoritos
Registrarse gratis ¿Ya tiene cuenta? Iniciar sesión
Cotizaciones
Todos los instrumentos
- Todos los instrumentos
- Índices
- Acciones
- ETFs
- Fondos
- Materias primas
- Divisas
- Cripto
- Bonos
- Certificados
Por favor, inténtelo con una nueva búsqueda
¡Horas finales! Ahorra hasta un 55% InvestingPro
QUIERO MI OFERTA
Axa Framlington Health Fund Z Acc (0P0000XMSV)
Agregar/Eliminar del portafolio
Agregar a portafolio
4.17
-0.07
-1.72%
19/12 - Mercado cerrado. Valores en GBP
Tipo:
Fondo
Mercado:
Reino Unido
Emisor:
AXA Investment Managers UK Ltd
ISIN:
GB00B6WZJX05
Clase de activo:
Acciones
- Rating de Morningstar:
- Total de activos: 548.98M
AXA Framlington Health Fund Z GBP Acc
4.17
-0.07
-1.72%
Panorama 0P0000XMSV
En esta página encontrará un perfil detallado de Axa Framlington Health Fund Z Acc. Conozca la gestión clave, los activos totales, la estrategia de inversión y la información de contacto de 0P0000XMSV, entre otros datos.
Información de contacto
Dirección
100, Esplanade du Général de Gaulle
Paris, 92932
France
Paris, 92932
France
Telefono
+33 1 44 45 70 00
Fax
Paris
Ejecutivos
| Nombre | Título | Desde | Hasta |
|---|---|---|---|
| Catherine Tennyson | - | 2024 | Ahora |
| Chris Eccles | Research Analyst | 2024 | Ahora |
| Biografía | Chris Eccles is a research analyst who specialises in testing and regulatory affairs. He researches stocks globally and focuses on the Healthcare sector. Chris joined Impax in March 2019. He started working in the financial industry in 2011 as a research analyst at Morgan Stanley where he focused on European large-cap pharmaceuticals. In 2014, he became a partner at the hedge fund Kola Capital where he worked as a global equities analyst for three years before moving to Stifel in 2017 to work as a Healthcare Specialist. Chris achieved an MA (Oxon) Physiological Sciences First Class Honours, from the University of Oxford. | ||
| Cinney Zhang | - | 2023 | Ahora |
| Linden Thomson | - | 1987 | 2024 |
| Peter Hughes | Portfolio Manager | 2021 | 2023 |
| Biografía | Peter joined Redwheel in July 2023 as a Partner and Portfolio Manager. He will manage the Redwheel Life Changing Treatments strategy. His ambition for the role is to focus on improving patients’ lives, regardless of where they live by investing in companies facilitating improved health care outcomes while providing long-term capital appreciation for investors. Before Redwheel, Peter was Portfolio Manager of the AXA World Funds Longevity Economy fund and AXA Framlington Health fund, specialising in healthcare. Before this, he held appointments at Architas, in roles covering investment research and relationship management. Peter holds a PhD in biochemistry from University College London. He has a master's degree in chemistry from the University of Surrey and is a CFA Charterholder. He is also an ambassador for the Royal Marsden Cancer Charity. Peter was named as a 2021 Rising Star of Asset Management by Financial News. | ||
| Dani Saurymper | - | 2015 | 2021 |
| Biografía | Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare. | ||
| Mark Hargraves | Portfolio Manager | 2014 | 2016 |
| Biografía | Mark attended the University of Bristol gaining a Geography BSc (Hons). In 2000, he obtained a Masters in Finance from the London Business School. He is also a member of the UK Society of Investment Professionals. Mark spent two years working for Abbey National plc and then moved to Hambros Fund Management as assistant portfolio manager European Equities. In 1997, he joined United Friendly Asset Management as a fund manager for European Equities. Mark joined AXA Framlington as a fund manager in June 2000. | ||
| Gemma Game | - | 2011 | 2014 |
| Deane Donnigan | clinical Specialist | 1997 | 2011 |
| Biografía | Deane joined Polar Capital in June 2013 as a senior analyst for the Healthcare team and has over 34 years’ industry experience, including over 15 years within healthcare asset management. She trained as a clinical pharmacist, graduating with a post baccalaureate Doctor of Pharmacy from the University of Georgia. Deane began her career at the Medical College of Georgia, before becoming a clinical specialist in Drug Information and Adult Internal Medicine with Emory University Hospital in Atlanta, Georgia. After several years, she moved to the UK to join Framlington (now AXA Framlington) applying her extensive pharmaceutical expertise working as an analyst for the healthcare unit trust, led by Anthony Milford. She went on to become lead portfolio manager of the Framlington Healthcare and Framlington Biotechnology funds. Deane is both a US and UK citizen. | ||
| Antony Milford | - | 1987 | 2007 |
Escribe tus pensamientos respecto al Axa Framlington Health Fund Z Acc
¿Estás seguro que quieres borrar este gráfico?
Eliminar Cancelar
¿Sustituir el gráfico adjunto por un nuevo gráfico?
Sustituir Cancelar
Guía para comentarios
Adjuntar un gráfico al comentario
Confirmar bloqueo
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Denunciar este comentario
Díganos qué piensa de este comentario
Comentario denunciado
Gracias
Su denuncia será examinada por nuestros moderadores